A. Tangpeerachaikul

Mediator Kinase Inhibition Further Activates Super-Enhancer Associated Genes in AML

S. Armstrong, R. Bronson, Christopher C. Ebmeier, 2015, Nature.

Diels-Alder cycloaddition for fluorophore targeting to specific proteins inside living cells.

Michael T. Taylor, A. Ting, J. Fox, 2012, Journal of the American Chemical Society.

Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics.

Christopher C. Ebmeier, D. Taatjes, R. Dowell, 2016, Cell reports.

NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations

A. Drilon, S. Ou, D. Camidge, 2022, Cancer discovery.

Fast, cell-compatible click chemistry with copper-chelating azides for biomolecular labeling.

Scott T. Clarke, A. Ting, K. Gee, 2012, Angewandte Chemie.

Abstract 1468: NUV-655 (NVL-655) is a selective, brain-penetrant ALK inhibitor with antitumor activity against the lorlatinib-resistant G1202R/L1196M compound mutation

N. Kohl, J. Horan, H. Pelish, 2021, Experimental and Molecular Therapeutics.

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

A. Drilon, H. Pelish, M. Shair, 2024, Cancer discovery.